Atlas Trials

Famotidine in Schizophrenia

Clinical trial NCT01946295 · UNKNOWN

Trial details

NCT number
NCT01946295
Sponsor
Jesper Ekelund
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2014-03-01
Primary completion
2016-08-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.